Showing results (431-440 of 1,274) with videos related to

Sort By:
Pageof 128
Veterinary and Comparative Oncology|November 15, 2011
Single-agent gemcitabine chemotherapy in dogs with hepatocellular carcinomasA K Elpiner, E M Brodsky, T N Hazzah, et al.
Veterinary and Comparative Oncology|November 15, 2011
Phase I/II clinical trial of 2-difluoromethyl-ornithine (DFMO) and a novel polyamine transport inhibitor (MQT 1426) for feline oral squamous cell carcinomaK A Skorupski, T G O'Brien, T Guerrero, et al.
Veterinary and Comparative Oncology|November 15, 2011
A randomized controlled study into the efficacy and toxicity of pegylated liposome encapsulated doxorubicin as an adjuvant therapy in dogs with splenic haemangiosarcomaE Teske, G R Rutteman, J Kirpenstein, et al.
Veterinary and Comparative Oncology|November 15, 2011
Mast cells in canine mammary gland tumour: number, distribution and EPOR positivityA Sfacteria, G Lanteri, G Grasso, et al.
Veterinary and Comparative Oncology|August 19, 2011
Epidermal growth factor enhances the malignant phenotype in canine mammary carcinoma cell linesK C Kennedy, B A Qurollo, B J Rose, et al.
Veterinary and Comparative Oncology|February 3, 2012
Clinical, histopathological and immunohistochemical characterization of canine indolent lymphomaK E Flood-Knapik, A C Durham, T P Gregor, et al.
Veterinary and Comparative Oncology|January 13, 2012
Serum neopterin, sialic acid and nitric oxide levels in dogs with malignant mammary tumoursN Tascene, G Kısmalı, S Vural, et al.
Veterinary and Comparative Oncology|January 13, 2012
Investigation of a screening programme and the possible identification of biomarkers for early disseminated histiocytic sarcoma in Bernese Mountain dogsL N Nielsen, F McEvoy, L R Jessen, et al.
Veterinary and Comparative Oncology|January 13, 2012
Safety evaluation of combination vinblastine and toceranib phosphate (Palladia®) in dogs: a phase I dose-finding studyC Robat, C London, L Bunting, et al.
Veterinary and Comparative Oncology|January 13, 2012
Safety evaluation of combination toceranib phosphate (Palladia®) and piroxicam in tumour-bearing dogs (excluding mast cell tumours): a phase I dose-finding studyE Chon, L McCartan, L N Kubicek, et al.
Pageof 128